Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee
- PMID: 11399102
- DOI: 10.1053/joca.2000.0398
Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee
Abstract
Objective: Histomorphometric study on cartilage samples taken from osteoarthritic human knees before and 6 months after intraarticular injections of a specific fraction (500-730 kDa) of hyaluronan. The results obtained with hyaluronan were compared with the results of methylprednisolone acetate treatment.
Methods: Twenty-four subjects with primary osteoarthritis (OA) of the knee were considered. Eleven patients were treated with Hyaluronan (Hyalgan), 20 mg/2 ml once a week for 5 weeks) and 13 with methylprednisolone (Depo-Medrol, 40 mg/1 ml once a week for 3 weeks). At the time of baseline and after 6 months from the start of treatment, biopsies of cartilage were taken and processed for electron microscopy. Articular surface morphology, territorial matrix, chondrocyte number and ultrastructure were characterized by a set of morphometric parameters. Samples from 19 informed patients showing no arthroscopic sign of OA were also used for comparison.
Results: Six months after hyaluronan treatment a significant reconstitution of the superficial layer were observed together with an improvement in chondrocyte density and territorial matrix appearance. Furthermore, chondrocytes appeared significantly improved in their metabolism, as indicated by the increased extension of the synthetic structures and mitochondria with respect to the organelles having catabolic or storage functions. Hyaluronan treatment produced results that were significantly superior to those delivered with Methylprednisolone in almost all the morphometric estimators.
Conclusions: These results cannot be explained simply by temporary restoration of the synovial fluid viscoelasticity, and provide further evidence that the specific fraction of hyaluronan used in this study is a useful tool in OA treatment, with a potential structure-modifying activity.
Copyright 2001 OsteoArthritis Research Society International.
Similar articles
-
Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis.Rheumatology (Oxford). 2001 Feb;40(2):158-69. doi: 10.1093/rheumatology/40.2.158. Rheumatology (Oxford). 2001. PMID: 11257152 Clinical Trial.
-
A hyaluronan preparation (500-730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan.Int J Clin Pract. 2002 Dec;56(10):804-13. Int J Clin Pract. 2002. PMID: 12510956 Review.
-
Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development.Arthritis Rheum. 2007 Oct;56(10):3307-18. doi: 10.1002/art.22917. Arthritis Rheum. 2007. PMID: 17907184
-
Combination of intra-articular autologous activated peripheral blood stem cells with growth factor addition/ preservation and hyaluronic acid in conjunction with arthroscopic microdrilling mesenchymal cell stimulation Improves quality of life and regenerates articular cartilage in early osteoarthritic knee disease.J Med Assoc Thai. 2013 May;96(5):580-8. J Med Assoc Thai. 2013. PMID: 23745314
-
Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?Semin Arthritis Rheum. 2002 Aug;32(1):10-37. doi: 10.1053/sarh.2002.33720. Semin Arthritis Rheum. 2002. PMID: 12219318 Review.
Cited by
-
Effectiveness and utility of hyaluronic acid in osteoarthritis.Clin Cases Miner Bone Metab. 2015 Jan-Apr;12(1):31-3. doi: 10.11138/ccmbm/2015.12.1.031. Clin Cases Miner Bone Metab. 2015. PMID: 26136793 Free PMC article. Review.
-
Intra-articular glenohumeral injections of HYADD®4-G for the treatment of painful shoulder osteoarthritis: a prospective multicenter, open-label trial.Joints. 2016 Jan 28;3(3):116-21. doi: 10.11138/jts/2015.3.3.116. eCollection 2015 Jul-Sep. Joints. 2016. PMID: 26889467 Free PMC article.
-
Status of hyaluronan supplementation therapy in osteoarthritis.Curr Rheumatol Rep. 2003 Feb;5(1):7-14. doi: 10.1007/s11926-003-0077-6. Curr Rheumatol Rep. 2003. PMID: 12590879 Review.
-
Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) shows no change in cartilage structural composition after viscosupplementation in patients with early-stage knee osteoarthritis.PLoS One. 2013 Nov 6;8(11):e79785. doi: 10.1371/journal.pone.0079785. eCollection 2013. PLoS One. 2013. PMID: 24223194 Free PMC article. Clinical Trial.
-
Experimental osteoarthritis model by means of medial meniscectomy in rats and effects of diacerein administration and hyaluronic acid injection.Sao Paulo Med J. 2015 Feb;133(1):4-12. doi: 10.1590/1516-3180.2013.6730001. Epub 2014 Nov 28. Sao Paulo Med J. 2015. PMID: 25424775 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources